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Over the past decades there has been a tremendous blossoming in both
biotechnology and nanoscience. These advances have come through prog-
ress in techniques and instrumentation, step-changes in understanding, as
well as the hard graft of innumerable scientists (thanks especially to the
rapid growth outside of the US and Europe).
A common foundation for the two fields has been (and indeed one could
argue must be) recognised: biology (protein, DNA, and lipid assemblies)
transmits its functional effects on the nanoscale. This seemingly semantic
point is more than that; the glib comment that ‘Chemistry is
nanotechnology’ misses an essential distinction that the distances, levers,
forces and transformations (including those that may drive bond manipula-
tion) accomplished in biology are the product of effects transmitted over
distance scales significantly larger than those found in small molecule
transition states. This distinction is strategically important in considering
how we interrogate the Chemistry of Biology; nanotechnology in this regard
can be considered to be a ‘size-matched’ tool. Nonetheless, Chemistry acts
as a shared language and provides a lens through which to understand core
principles and tools to create new systems. New and interesting effects
should therefore be expected to arise from the interaction of anthropogenic
nanotechnology with Biology, whether through influence of nanomaterials
on living systems, or by harnessing nature’s nanoscale factories to fabricate
our own designs. Fruitful crossover is also to be expected (and now
increasingly observed) from use of shared analytical techniques. Nonethe-
less, the interface between the two fields is even less well understood than
each individual area. Moreover, as both nanotech and biotech edge towards
maturity, there is increasing pressure to deliver real-life applications. These
impulses bring in the expertise of engineers and medical practitioners,
further expanding the interdisciplinarity.
While there can be no doubt that there is enormous promise, there has at the
same time also been a proliferation of fashions, buzzwords, and hype.
Sometimes it has perhaps been all too tempting to use ‘nano-something’
to increase the profile of a bioscience paper, and vice versa. How much of this
is useful? Our view is that the most transformational and translational
technologies will emerge when nanotechnology brings some aspect of
complete novelty to biology, or vice versa, leading to something greater
than the sum of the parts [1]. Fittingly, ‘greater than the sum of its parts’
could be said to be the trait most strikingly manifest in living systems, which
achieve outcomes well beyond our technological capability on the basis of
simple molecular building blocks assembled through the functional filter of
fitness; the resulting complexity solves problems that are typically beyond
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the reach of any blockwise, homogeneous design. In this Special Issue, we
have chosen to highlight specifically the ‘two-way traffic’ between these
disciplines — we have aimed to highlight examples of unique possibilities
being raised in bio-technology or nano-technology through contribution of
the other.
Using biotechnology to advance nanoscience
In the first set of examples, biology provides tools to create nanostructures
which would be otherwise inaccessible. The diversity of natural peptides is
both a strength and challenge for nanotechnology. Slocik and Naik [2] lay
out how sequenced biomolecules like peptides and oligonucleotides can
lead to highly selective binders for nanomaterials, and act as adjuncts to
control size and shape. Improvements in methods for selection and sequenc-
ing through phage display are documented, as are applications as diverse as
strengthening steel and adherence of hair dye. At the next scale up, Voet and
Tame document the ability of full proteins to template inorganic nanopar-
ticles [3]. Starting with more obvious cage-type proteins (ferritin, viruses),
the review moves to less intuitive, but readily available templates like
bovine serum albumin and lysozyme to generate nanoparticles and nano-
wires. The discussion moves on to a particularly impressive achievement —
the templation of the smallest mineral crystal yet characterised structurally.
Kobayashi and Arai set out the latest developments in design of nanos-
tructures using proteins themselves as building blocks [4]. While DNA
nanotechnology has succeeded because of its simplicity, the very sophisti-
cation of proteins has made it much more difficult to create programmed
non-natural nanostructures. However, some design rules for production of
artificial protein structures are now being elucidated using the fusion of self-
assembling protein domains.
Using nanoscience to advance biotechnology
The second set of reviews explore the use of nanotechnological methods to
solve problems in biotechnology. Membrane proteins are key players in
cellular processes, providing contact with the outside world, yet their full
characterisation remains a challenge. Their native folding and function
requires membrane incorporation, yet lipid systems are sensitive and tem-
peramental. Hu et al. discuss the use of synthetic polymersome systems as
hosts for analysis of membrane proteins [5]. Polymersomes are potent tools,
providing both robustness and customisability, and can be integrated with
cell-free protein synthesis. Stem cells, another promising technology, have
the potential to revolutionise regenerational medicine but control of their
differentiation into functional tissues is still poorly understood. The vast
parameter space available in choice of environmental conditions which can
lead to the formation of one type of cell rather than another is a significant
challenge. Tronser et al. discuss the miniaturisation of high-throughput
arrays designed to discover these conditions [6]. Both the construction of
high-density arrays, and the creation of specific environments akin to the
extracellular matrix are examined. Another problem in biotechnology is the
phenomenon of the protein corona. Nanomaterials in biological fluids tend
to adsorb various proteins, creating an external shell. Since this covering will
necessarily affect the chemical and physical properties of the particles,
knowledge of its extent and nature are essential for successful deployment
of nanobiotechnologies. Carrillo-Carrion et al. expound the techniques
available to answer this question [7]. The field is divided into ‘direct’
methods which probe the protein layer itself and can identify its composi-
tion, and ‘indirect’ methods which rely on gross changes to infer details of
the protein corona.
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Mimicking, exploiting, and influencing
biological processes with nanotechnology
Next, we go beyond structural studies to look at the
interface of nanotechnology with biological processes.
One characteristic of living systems is that they operate
far from equilibrium — there is a constant need for inputs
and outputs to drive processes energetically uphill; the
translation of this principle into nanotechnology is out-
lined by della Sala et al. [8]. By tethering nanoscale self-
assembly to chemical oscillations, it is possible to mimic
Biology in terms of control over structure in the temporal
domain. Examples of this include cycling gelators, and
transient vesicular systems. DelRosso and Derr then take
us through nature’s conveyor belts — cytoskeletal trans-
port mechanisms [9]. These are the gold standard of
nanoscale transport — directional, long range, and effi-
cient. Efforts to exploit and mimic these systems for
controlled delivery of non-natural cargo are explored,
and purely synthetic examples of genuine nanoscale
walking machines showcased. Conversely, Giessen and
Silver discuss efforts towards using nanotechnology to
improve biological processes, photosynthesis in this case
[10]. Carbon fixation is a growing problem and current
crops are poorly optimised to tackle it; the review shows
how engineering of chloroplasts to ensure the most effi-
cient conversion of carbonate into sugars can yield poten-
tially game-changing new technologies.
Nanobiotechnology in the field
Our final block of perspectives looks at how nanobio-
technologies bring something new to real life settings.
Scheinberg et al. assess the progress that nanotechnology
has made in the clinic [11]. Highlighting the general
benefits of multivalency and multifunctionality that
nanomaterials display, the still poorly understood phar-
macology is reviewed. Outstanding examples in the fields
of imaging, therapeutics (including non-liposomal cases),
and external sensors are presented, and the hurdles and
opportunities ahead scoped out. Strauss and Chmielewski
take a closer look at one case — the use of self-assembling
collagen mimetic peptides to create customisable matri-
ces for tissue regeneration [12]. The strategies needed to
generate assemblies from the molecular level, through
the nanoscale, to macroscopic materials are presented,
followed by exciting results on the growth of cells in the
matrices. As well as the anticipated benefits, nanotech-
nology can also bring unexpected novelties. For indus-
tries in nanotechnology, the risk of causing harm to
humans or the ecosystems must be managed, while still
leaving room for innovation to flourish. Auty addresses
these questions through the lens of risk appetite [13]. The
toxicological risks associated with nanotechnologies are
reviewed, and a control banding scheme proposed as a
way to manage such aspects of these highly promising
materials. Lastly, the final destination and effects of
nanomaterials in the ecosystem is clearly an important
area of concern, as the number of nanoparticle-containing
products rapidly increases. Mottier et al. look at the risk
posed by such xenobiotic materials in the environment
[14]. Taking carbon nanomaterials as a case study, the
difficulties of detection, and questions of aging and
transformation are discussed. The effects of carbon nano-
materials on amphibians and photosynthetic microorgan-
isms have been determined experimentally, and the
significance of these findings is highlighted. This per-
spective serves as a valuable signpost for future manage-
ment of nanomaterials in the ecosystem.
We hope that this collection of perspectives will showcase
what is genuinely new and exciting at the interface of
nanotechnology and biotechnology, and inspire readers to
move forward to conceive new possibilities and applica-
tions that fully exploit the common foundations of the
two areas.
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